Concepedia

Author

Yoshinori Miyazaki

The University of Texas Health Science Center at San Antonio

Also Known As

YOSHINORI MIYAZAKI, Yoshinori MIYAZAKI, Yoshinori Miyazaki

51

Publications

6.8K

Citations

23

H-Index

33

Concepts

All Affiliations

The University of Texas Health Science Center at San AntonioTexas Diabetes InstituteSapporo Medical UniversityUniversity of PisaIstituto di Fisiologia Clinica
YM

About

Yoshinori Miyazaki is an author at The University of Texas Health Science Center at San Antonio specializing in diabetes, medicine, and physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

1.2K

2

Health Sciences

8

8

1.2K

3

Biochemistry

2

2

129

4

Social Sciences

1

1

16

5

Applied Physiology

1

1

16

Yoshinori Miyazaki

×

30

Publications

6.8K

Citations

23

H-Index

YearCitations

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of<i>PGC1</i>and<i>NRF1</i>

Mary‐Elizabeth Patti, Atul J. Butte, Sarah Crunkhorn,

Proceedings of the National Academy of Sciences

2003

1.9K

Effect of Pioglitazone on Abdominal Fat Distribution and Insulin Sensitivity in Type 2 Diabetic Patients

Yoshinori Miyazaki, Archana Mahankali, Masafumi Matsuda,

The Journal of Clinical Endocrinology & Metabolism

2002

695

Relationship Between Hepatic/Visceral Fat and Hepatic Insulin Resistance in Nondiabetic and Type 2 Diabetic Subjects

Amalia Gastaldelli, Kenneth Cusi, Maura Pettiti,

Gastroenterology

2007

603

β-Cell Function in Subjects Spanning the Range from Normal Glucose Tolerance to Overt Diabetes: A New Analysis

Ele Ferrannini, Amalia Gastaldelli, Yoshinori Miyazaki,

The Journal of Clinical Endocrinology & Metabolism

2005

531

Improved Glycemic Control and Enhanced Insulin Sensitivity in Type 2 Diabetic Subjects Treated With Pioglitazone

Yoshinori Miyazaki, Archana Mahankali, Masafumi Matsuda,

Diabetes Care

2001

404

Decreased Plasma Adiponectin Concentrations Are Closely Related to Hepatic Fat Content and Hepatic Insulin Resistance in Pioglitazone-Treated Type 2 Diabetic Patients

Mandeep Bajaj, Swangjit Suraamornkul, Paul K. Piper,

The Journal of Clinical Endocrinology & Metabolism

2004

356

Pioglitazone Reduces Hepatic Fat Content and Augments Splanchnic Glucose Uptake in Patients With Type 2 Diabetes

Mandeep Bajaj, Swangjit Suraamornkul, Thongchai Pratipanawatr,

Diabetes

2003

291

Metabolic Effects of Visceral Fat Accumulation in Type 2 Diabetes

Amalia Gastaldelli, Yoshinori Miyazaki, Maura Pettiti,

The Journal of Clinical Endocrinology & Metabolism

2002

283

Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus

Yoshinori Miyazaki, Leonard C. Glass, Curtis Triplitt,

American Journal of Physiology-Endocrinology and Metabolism

2002

255

Dose-Response Effect of Pioglitazone on Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes

Yoshinori Miyazaki, Masafumi Matsuda, Ralph A. DeFronzo

Diabetes Care

2002

233

Page 1